Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Allogene Therapeutics
ALLO
$708M
| $2.77M | ﹤0.01% |
+440,100
| New | +$4.07M |
|
1877
Cohu
COHU
$2.81B
| $2.77M | ﹤0.01% |
86,354
-79,600
| -48% | -$2.58M |
|
1878
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
$42B
| $2.77M | ﹤0.01% |
67,786
-2,914
| -4% | -$124K |
|
|
PAYA
1879
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $2.77M | ﹤0.01% |
351,500
+40,300
| +13% | +$311K |
|
1880
Daktronics
DAKT
$986M
| $2.76M | ﹤0.01% |
979,548
-103,900
| -10% | -$319K |
|
1881
Ecovyst
ECVT
$1.14B
| $2.75M | ﹤0.01% |
310,500
+129,400
| +71% | +$1.19M |
|
1882
Credit Acceptance
CACC
$6.1B
| $2.75M | ﹤0.01% |
+5,788
| New | +$2.66M |
|
1883
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.75B
| $2.75M | ﹤0.01% |
58,200
+40,605
| +231% | +$1.91M |
|
1884
RF Industries
RFIL
$148M
| $2.75M | ﹤0.01% |
534,008
-17,800
| -3% | -$93.6K |
|
|
ETNB
1885
DELISTED
89bio
ETNB
| $2.74M | ﹤0.01% |
215,167
-18,600
| -8% | -$167K |
|
|
IBTX
1886
DELISTED
Independent Bank Group, Inc.
IBTX
| $2.74M | ﹤0.01% |
45,543
+27,800
| +157% | +$1.77M |
|
1887
LXP Industrial Trust
LXP
$3.57B
| $2.73M | ﹤0.01% |
54,596
-11,140
| -17% | -$557K |
|
1888
Broadstone Net Lease
BNL
$4.38B
| $2.73M | ﹤0.01% |
168,300
-183,500
| -52% | -$3.07M |
|
1889
BlackBerry
BB
$5.22B
| $2.72M | ﹤0.01% |
833,543
+229,700
| +38% | +$1.02M |
|
|
STCN
1890
DELISTED
Steel Connect, Inc. Common Stock
STCN
| $2.72M | ﹤0.01% |
203,550
-22,950
| -10% | -$283K |
|
1891
Manitowoc
MTW
$746M
| $2.71M | ﹤0.01% |
295,849
-97,600
| -25% | -$891K |
|
1892
Distribution Solutions Group
DSGR
$1.62B
| $2.71M | ﹤0.01% |
147,000
-37,760
| -20% | -$634K |
|
1893
AerSale
ASLE
$280M
| $2.7M | ﹤0.01% |
166,700
+83,500
| +100% | +$1.45M |
|
1894
ADMA Biologics
ADMA
$2.12B
| $2.7M | ﹤0.01% |
695,935
+57,535
| +9% | +$177K |
|
1895
Selective Insurance
SIGI
$5.62B
| $2.69M | ﹤0.01% |
+30,394
| New | +$2.77M |
|
1896
dLocal
DLO
$4.17B
| $2.69M | ﹤0.01% |
172,900
+77,900
| +82% | +$1.37M |
|
1897
Turning Point Brands
TPB
$1.75B
| $2.69M | ﹤0.01% |
124,352
-2,700
| -2% | -$57.4K |
|
1898
Varex Imaging
VREX
$779M
| $2.69M | ﹤0.01% |
132,500
+1,500
| +1% | +$31.4K |
|
1899
Xencor
XNCR
$1.74B
| $2.69M | ﹤0.01% |
103,300
-10,700
| -9% | -$299K |
|
1900
Farmers National Banc Corp
FMNB
$966M
| $2.69M | ﹤0.01% |
190,284
-89,349
| -32% | -$1.26M |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.